Rita Omega Ella

  • Citations Per Year
Learn More
The aim of the analysis was to compare the outcome of heart failure patients in New York Heart Association (NYHA) class IV to that of NYHA class III patients 1 year after implantation of a CRT device. The analysis was based on the 405 CRT patients enrolled in the MASCOT trial. At enrollment, 350 patients (86 %) were in NYHA class III and 55 (14 %) were in(More)
BACKGROUND Cardiac resynchronization therapy (CRT) is an established therapy for patients with chronic heart failure (CHF) and a broad QRS complex. Gender-related safety and efficacy data are necessary for informed patient decision-making for female patients with CHF. The aim of the study was to assess the effects of gender on the outcome of CRT in highly(More)
BACKGROUND Clinical evaluation of renal denervation (RDN) as a therapy for uncontrolled hypertension continues. Current emphasis is on more rigorously controlled trials, including the controlling of technique variability and more efficient nerve inactivation. The Peregrine System Infusion Catheter is used to perform RDN via the delivery of alcohol into the(More)
BACKGROUND Left-ventricular ejection fraction (LVEF) is regarded as a strong predictor for morbidity and mortality in heart failure patients. The aim of the analysis was to assess the relationship between pre-implant LVEF and outcome of patients with advanced heart failure who received cardiac resynchronization therapy (CRT). METHODS We analysed the(More)
OBJECTIVE This study aimed to investigate the effects of renal denervation (RDN) on sympathetic nerve activity and insulin resistance in patients with metabolic syndrome. METHODS Seventeen patients fulfilled at least four of five criteria for metabolic syndrome and under stable use of at least two antihypertensive drugs were randomized in 3 : 1 ratio to(More)
  • 1